Synaptogenix

About:

Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Website: https://www.synaptogen.com

Twitter/X: synaptogenix

Top Investors: Bantam Group

Description:

Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1 and its analogs to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. The company has targeted Bryostatin-1 due to its high potential and multi-modal efficacy: through protein kinase C (PKCϵ) activation, Bryostatin-1 stimulates synaptic growth factors, amyloid-β degrading enzymes, as well as prevents Tau transformation into neurofibrillary tangles.